Anzeige
Meldung des Tages: 30 Jahre alte Daten könnten jetzt den nächsten großen Antimon-Fund freilegen

Quantum Biopharma News

Aktie
WKN:  A2P8F1 ISIN:  CA74764Y2050 US-Symbol:  QNTM Branche:  Biotechnologie Land:  Kanada
4,00 €
-0,04 €
-0,99%
25.03.26
Depot/Watchlist
Marktkapitalisierung *
26,93 Mio. €
Streubesitz
62,12%
KGV
-0,27
Index-Zuordnung
-

Quantum Biopharma News

19.02.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM ...
12.02.26 - PR Newswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming ...
29.01.26 - PR Newswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming ...
22.01.26 - PR Newswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming ...
15.01.26 - PR Newswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming ...
26.12.25 - PR Newswire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm PR Newswire
01.04.25 - IRW-Press
Quantum BioPharma gibt eine gemeinsame klinische Studie mit Wissenschaftlern des Massachusetts General Hospital bekannt
Quantum Biopharma gibt eine gemeinsame klinische Studie mit Wissenschaftlern des Massachusetts General Hospital bekannt, um eine neuartige Positronen-​Emissions-...
31.03.25 - IRW-Press
Geschäftsbericht 2024 von Quantum Biopharma zeigt starke Verbesserungen bei Barmitteln, Betriebskapital und Betriebseffizienz sowie Beseitigung von wesentlichen Unsicherheiten hinsichtlich laufendem Geschäft
Abschluss von klinischer Studie über unbuzzdTM und Phase-1-Studie über Multiple-​Sklerose-Medikament Lucid-21-302 erweitern die Produkt- und Assets-​Pipeline des ...

Newssuche

Videos

newspaper
23.03.26 +1,52%
Technical Trading: Gold Long nach Absturz
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »